U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.
Sanofi's head of vaccines David Loew will quit to become chief executive of Ipsen from July 1, the two French drugmakers said on Friday.
Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients.
Here's what you need to know about the coronavirus right now:
A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, it said in a stock exchange filing on Friday.
(This May 28 story, adds dropped word "Smart" in paragraph 4 and corrects designation in paragraph 12 to nurse, not doctor)
South Korean health authorities said on Friday they would request imports of Gilead Sciences Inc's anti-viral drug remdesivir to treat COVID-19, as new outbreaks of the disease flare as social distancing restrictions are eased.
China's Ministry of Agriculture and Rural Affairs said on Friday it had found a new outbreak of African swine fever near the city of Lanzhou in northwestern Gansu province.
A raft of South African tobacco companies, activists and associations are seeking legal action over the ban on cigarette sales during the country's coronavirus lockdown.
As India's health system grapples with the coronavirus, doctors are increasingly going online to consult with patients suffering less critical or chronic diseases, while the south Asian economy prepares to emerge from a nationwide lockdown.